SERUM CHROMIUM, MAGNESIUM AND ZINC LEVELS IN SUDANESE TYPE 2 DIABETIC PATIENTS
Abstract
Objectives: The purpose of this study was to evaluate the difference in serum chromium, magnesium and zinc levels between diabetic and control groups, and to determine the correlations between these elements and serum glucose in patients with type 2 diabetes mellitus.
Methods: Forty patients suffering from type 2 diabetes and 30 controls were selected randomly. The level of serum chromium, magnesium and zinc were measured and compared between the two groups. Correlations of serum Cr, Mg and Zn with serum glucose were conducted.
Results: There was a very significant difference in some serum trace elements level between diabetic and control groups. Serum magnesium and zinc were significantly lower in diabetic group compared with the control group (P= 0.014, P < 0.0001 respectively). Negative but not significant correlations were shown between Cr, Mg and Zn and serum glucose.
ConclusioN: There is trace elements metabolism disorder in patients with type 2 diabetes mellitus. Magnesium and zinc could be considered suitable for inclusion in a nutritional supplement for diabetes with significant value for the treatment of diabetics and prevention of complications.
References
2. Tolman, K. G., Fonseca, V., Tan, M. H. and Dalpiaz, A. Narrative review: hepatobiliary disease in type 2 diabetes mellitus. Ann Intern Med 2004; 141 (12): 946-956.
3. Ahmed, A. M. and Ahmed, N. H. Diabetes mellitus in Sudan: the size of the problem and the possibilities of efficient care. Practical Diabetes Int 2001; 18 (9): 324–327.
4. Fritsche, A., Thamer, C., Stefan, N. and Haring, H. U. [Gene-environment interactions in the pathogenesis and prevention of type 2 diabetes mellitus]. Internist (Berl) 2007; 48 (7): 669-670, 672, 665-674.
5. Kazi, T. G., Afridi, H. I., Kazi, N., Jamali, M. K., Arain, M. B., Jalbani, N. and Kandhro, G. A. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res 2008; 122 (1): 1-18.
6. Chen, M. D., Lin, P. Y., Tsou, C. T., Wang, J. J. and Lin, W. H. Selected metals status in patients with noninsulin-dependent diabetes mellitus. Biol Trace Elem Res 1995; 50 (2): 119-124.
7. Geohas, J., Daly, A., Juturu, V., Finch, M. and Komorowski, J. R. Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Am J Med Sci 2007; 333 (3): 145-153.
8. Balk, E. M., Tatsioni, A., Lichtenstein, A. H., Lau, J. and Pittas, A. G. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care 2007; 30 (8): 2154-2163.
9. Jain, S. K., Rains, J. L. and Croad, J. L. High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes. Antioxid Redox Signal 2007; 9 (10): 1581-1590.
10. Simmons, D., Joshi, S. and Shaw, J. Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract 2010; 87 (2): 261-266.
11. Al-Osali, M. E., Al-Qassabi, S. S. and ElSayed, M. K. Hypomagnesemia in type 2 diabetic Omani patients. Saudi Med J 2009; 30 (7): 897-901.
12. Villegas, R., Gao, Y. T., Dai, Q., Yang, G., Cai, H., Li, H., Zheng, W. and Shu, X. O. Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women's Health Study. Am J Clin Nutr 2009; 89 (4): 1059-1067.
13. Bjelakovic, G., Sokolovic, D., Ljiljana, S., Kocic, G., Jevtovic, T., Stojanovic, I., Ilic, M., Bjelakovic, L., Zivic, S., Pavlovic, D., Nikolic, J. and Basic, J. Arginase activity and magnesium levels in blood of children with diabetes mellitus. J Basic Clin Physiol Pharmacol 2009; 20 (4): 319-334.
14. Curiel-Garcia, J. A., Rodriguez-Moran, M. and Guerrero-Romero, F. Hypomagnesemia and mortality in patients with type 2 diabetes. Magnes Res 2008; 21 (3): 163-166.
15. Islam, M. S. and Loots du, T. Diabetes, metallothionein, and zinc interactions: a review. Biofactors 2007; 29 (4): 203-212.
